Brazil NGO opposes Gilead`s AIDS drug patent
Author: Business Standard [India], Published on: 27 June 2008
The Brazilian Interdisciplinary AIDS Association (ABIA), a non-governmental organisation (NGO) has joined Indian patient groups in opposing a patent application for Tenofovir (commonly known as Viread), a key AIDS drug marketed by Gilead Sciences in India. This is the first time a foreign patient group has decided to oppose an Indian patent application on the grounds that an India patent would have a direct impact on Brazil's chances to produce and access affordable generic versions of the drug... Civil society groups have also filed an opposition to Gilead's patent application in Brazil.
Related companies: Gilead Sciences